Saunders H, Chio U, Moore C, Ramani V, Cheng Y, Narlikar G
bioRxiv. 2024; .
PMID: 39229246
PMC: 11370580.
DOI: 10.1101/2024.08.23.609244.
Rezzani R, Favero G, Cominelli G, Pinto D, Rinaldi F
Int J Mol Sci. 2024; 25(15).
PMID: 39125810
PMC: 11311626.
DOI: 10.3390/ijms25158238.
Homma H, Tanaka H, Fujita K, Okazawa H
Int J Mol Sci. 2024; 25(7).
PMID: 38612448
PMC: 11012149.
DOI: 10.3390/ijms25073636.
Choijookhuu N, Yano K, Lkham-Erdene B, Shirouzu S, Kubota T, Fidya
J Histochem Cytochem. 2024; 72(4):245-264.
PMID: 38544368
PMC: 11020747.
DOI: 10.1369/00221554241241569.
Salamini-Montemurri M, Vizoso-Vazquez A, Barreiro-Alonso A, Lorenzo-Catoira L, Rodriguez-Belmonte E, Cerdan M
Int J Mol Sci. 2024; 25(6).
PMID: 38542079
PMC: 10969884.
DOI: 10.3390/ijms25063106.
Hmo1 Promotes Efficient Transcription Elongation by RNA Polymerase I in .
Huffines A, Schneider D
Genes (Basel). 2024; 15(2).
PMID: 38397236
PMC: 10888141.
DOI: 10.3390/genes15020247.
The acidic intrinsically disordered region of the inflammatory mediator HMGB1 mediates fuzzy interactions with CXCL12.
Mantonico M, De Leo F, Quilici G, Colley L, De Marchis F, Crippa M
Nat Commun. 2024; 15(1):1201.
PMID: 38331917
PMC: 10853541.
DOI: 10.1038/s41467-024-45505-7.
The expression of high mobility group protein 3 () in breast cancer with emphasis on its role in lymphovascular invasion.
Aljohani A, Alsaeed S, Toss M, Raafat S, Green A, Rakha E
Am J Cancer Res. 2023; 13(11):5334-5351.
PMID: 38058796
PMC: 10695817.
Adenovirus protein VII binds the A-box of HMGB1 to repress interferon responses.
Arnold E, Kaai R, Leung K, Brinkley M, Kelnhofer-Millevolte L, Guo M
PLoS Pathog. 2023; 19(9):e1011633.
PMID: 37703278
PMC: 10519595.
DOI: 10.1371/journal.ppat.1011633.
The Role of Box A of in Enhancing Stem Cell Properties of Human Mesenchymal Cells: A Novel Approach for the Pursuit of Anti-aging Therapy.
Ei Z, Mutirangura A, Arunmanee W, Chanvorachote P
In Vivo. 2023; 37(5):2006-2017.
PMID: 37652483
PMC: 10500522.
DOI: 10.21873/invivo.13298.
Fiber Optic Localized Surface Plasmon Resonance Sensor Based on Carboxymethylated Dextran Modified Gold Nanoparticles Surface for High Mobility Group Box 1 (HMGB1) Analysis.
Chiang C, Chen C, Wu C
Biosensors (Basel). 2023; 13(5).
PMID: 37232883
PMC: 10216769.
DOI: 10.3390/bios13050522.
Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma.
Mender I, Siteni S, Barron S, Flusche A, Kubota N, Yu C
Mol Cancer Ther. 2023; 22(6):737-750.
PMID: 37070671
PMC: 10233358.
DOI: 10.1158/1535-7163.MCT-23-0039.
High Mobility Group Box 1 (HMGB1): Potential Target in Sepsis-Associated Encephalopathy.
DeWulf B, Minsart L, Verdonk F, Kruys V, Piagnerelli M, Maze M
Cells. 2023; 12(7).
PMID: 37048161
PMC: 10093266.
DOI: 10.3390/cells12071088.
Negatively charged, intrinsically disordered regions can accelerate target search by DNA-binding proteins.
Wang X, Bigman L, Greenblatt H, Yu B, Levy Y, Iwahara J
Nucleic Acids Res. 2023; 51(10):4701-4712.
PMID: 36774964
PMC: 10250230.
DOI: 10.1093/nar/gkad045.
The Role of PARP1 and PAR in ATP-Independent Nucleosome Reorganisation during the DNA Damage Response.
Belousova E, Lavrik O
Genes (Basel). 2023; 14(1).
PMID: 36672853
PMC: 9859207.
DOI: 10.3390/genes14010112.
The DNA binding high mobility group box protein family functionally binds RNA.
Hamilton D, Hein A, Wuttke D, Batey R
Wiley Interdiscip Rev RNA. 2023; 14(5):e1778.
PMID: 36646476
PMC: 10349909.
DOI: 10.1002/wrna.1778.
Tanshinone IIA (TSIIA) represses the progression of non-small cell lung cancer by the circ_0020123/miR-1299/HMGB3 pathway.
Sun F, Yang X, Song W, Yu N, Lin Q
Mol Cell Biochem. 2022; 478(9):1973-1986.
PMID: 36586093
DOI: 10.1007/s11010-022-04646-3.
Snf2 Proteins Are Required to Generate Gamete Pronuclei in .
Fukuda Y, Akematsu T, Bando H, Kato K
Microorganisms. 2022; 10(12).
PMID: 36557679
PMC: 9786623.
DOI: 10.3390/microorganisms10122426.
PfHMGB2 has a role in malaria parasite mosquito infection.
Kumar S, Kappe S
Front Cell Infect Microbiol. 2022; 12:1003214.
PMID: 36506024
PMC: 9732239.
DOI: 10.3389/fcimb.2022.1003214.
Gastric alarmin release: A warning signal in the development of gastric mucosal diseases.
Wu E, Zhu J, Ma Z, Tuo B, Terai S, Mizuno K
Front Immunol. 2022; 13:1008047.
PMID: 36275647
PMC: 9583272.
DOI: 10.3389/fimmu.2022.1008047.